| Childhood Ependymal Tumor studied in …STUDIED_INderived33 of 33show fewer |
|---|
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359565Phase 1 · active not recruiting Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155920Phase 2 · completed Everolimus for Children With Recurrent or Progressive Ependymoma · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206021Phase 1 · completed COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04408092early Phase 1 · completed Study of the Effect of GM-CSF on Macrophages in Ependymoma · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387020Phase 1 · completed Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684071Phase 2 · terminated Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919750completed Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381797Phase 2 · completed Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01407744completed Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01462695Phase 2 · completed Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095940Phase 1/Phase 2 · completed Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012181Phase 1 · completed Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004078Phase 2 · completed Irinotecan in Treating Children With Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077454Phase 1 · completed Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091182Phase 2 · completed Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101270Phase 1 · completed Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 33 trials mapped (3 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363272Phase 1 · completed Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 33 trials mapped (3 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |